Profil

Pinto Emmanuel

Département des sciences cliniques

Département des sciences de la santé publique

See author's contact details
Main Referenced Co-authors
Ansseau, Marc  (46)
Pitchot, William  (32)
Reggers, Jean  (26)
Hansenne, Michel  (21)
Scantamburlo, Gabrielle  (17)
Main Referenced Keywords
Female (10); Humans (10); Male (10); Adult (9); depression (4);
Main Referenced Unit & Research Centers
Centre de Neurosciences Comportementale et Cognitive (4)
Centre de Neurosciences Cognitives et Comportementales - ULiège [BE] (3)
Main Referenced Disciplines
Psychiatry (27)
Neurosciences & behavior (14)
Pharmacy, pharmacology & toxicology (7)
Neurology (4)
Treatment & clinical psychology (4)

Publications (total 52)

The most downloaded
5023 downloads
Pitchot, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2007). Syndrome de discontinuation associé aux antidépresseurs. Revue Médicale de Liège, 62, 1-4. https://hdl.handle.net/2268/9416

The most cited

251 citations (Scopus®)

Hansenne, M., Reggers, J., Pinto, E., Kjiri, K., Ajamier, A., & Ansseau, M. (1999). Temperament and character inventory (TCI) and depression. Journal of Psychiatric Research, 33 (1), 31-6. doi:10.1016/S0022-3956(98)00036-3 https://hdl.handle.net/2268/26151

Blairy, S., & Pinto, E. (2015). Il n'existe aucun traitement efficace de l'alcoolisme? In V. Seutin, J. Scuvée-Moreau, ... E. Quertemont, L'alcool en questions (pp. 129-141). Bruxelles, Belgium: Mardaga.

Blairy, S., & Pinto, E. (2015). Il n'existe aucun traitement efficace de l'alcoolisme? In V. Seutin, J. Scuvée-Moreau, ... E. Quertemont, L'alcool en questions (pp. 129-141). Bruxelles, Belgium: Mardaga.
Peer reviewed

PITCHOT, W., SCANTAMBURLO, G., Pinto, E., & Karila L. (2013). Addiction à la cocaine. Revue Médicale de Liège.
Peer reviewed

PITCHOT, W., & Pinto, E. (2011). Réunion de consensus sur la procédure de mise en observation. Acta Psychiatrica Belgica, 211.
Peer Reviewed verified by ORBi

Farcy, L., PIETTE, C., MAVROPOULOS, G., Pinto, E., Ansseau, M., & PITCHOT, W. (2010). Delirium et anorexie. Acta Psychiatrica Belgica, 110, 3-7.
Peer Reviewed verified by ORBi

PITCHOT, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2010). Guérir la dépression : une question d'objectif et de détermination. Revue Médicale de Liège, 65 (5-6), 370-380.
Peer reviewed

BEVE, A., BECK, E., Pinto, E., & Ansseau, M. (2010). Le cas clinique du mois. Syndrome de sécrétion inappropriée d'hormone antidiurétique (SIADH) induit par le valproate de sodium. Revue Médicale de Liège, 65 (1), 6-9.
Peer reviewed

Scantamburlo, G., Reggers, J., Hansenne, M., Pitchot, W., Pinto, E., Ansseau, M., & Legros, J.-J. (2010). Ocytocine plamsatique et dimensions de personnalité dans la dépression unipolaire. Encéphale (L'), 36, 17.
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Gorwood, P., Boni, C., Scantamburlo, G., Pitchot, W., & Ansseau, M. (2009). The TaqI A DRD2 polymorphism in type II alcohol dependence: a marker of age at onset or of a familial disease? Alcohol, 43 (4), 271-5. doi:10.1016/j.alcohol.2009.02.006
Peer reviewed

Pinto, E., & Ansseau, M. (2009). Facteurs genetiques de l'alcoolo-dependance Revue des principales donnees de la litterature. Encéphale (L'), 35 (5), 461-9. doi:10.1016/j.encep.2008.03.008
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Gorwood, P., BONI, C., Scantamburlo, G., Pitchot, W., & Ansseau, M. (2008). The short allele of the serotonin transporter promoter polymorphism influences relapse in alcohol dependence. Alcohol and Alcoholism, 43, 398-400. doi:10.1093/alcalc/agn015
Peer Reviewed verified by ORBi

Maquet, D., Jaspar, J., Lecart, M.-P., Faymonville, M., Crielaard, J.-M., Bève, E., Ansseau, M., Pinto, E., Haidon, M., & Croisier, J.-L. (2008). La marche du sujet fibromyalgique et d’un sujet dépressif est-elle différenciable ? Exploration de deux affections « voisines » à partir d’un accéléromètre tri-axial. Revue du Rhumatisme, 75, 1142.
Peer reviewed

Pitchot, W., Scantamburlo, G., Pinto, E., Hansenne, M., Reggers, J., Ansseau, M., & Legros, J.-J. (2008). Vasopressin-neurophysin and DST in major depression : Relationship with suicidal behavior. Journal of Psychiatric Research, 42, 684-688. doi:10.1016/j.jpsychires.2007.07.007
Peer Reviewed verified by ORBi

Pinto, E., Pitchot, W., & Ansseau, M. (2008). Les psychostimulants. Revue Médicale de Liège, 63, 411-416.
Peer reviewed

Ansseau, M., Scantamburlo, G., Pinto, E., & Pitchot, W. (2008). Neurobiologie et pharmacothérapie du trouble obsessionnel-compulsif. Revue Médicale de Liège, 63, 359-363.
Peer reviewed

Pitchot, W., Pinto, E., Scantamburlo, G., & Ansseau, M. (March 2007). Duloxetine in major depressed patients resistant to SSRIs or venlafaxine. European Psychiatry, 22 (Suppl. 1), 242. doi:10.1016/j.eurpsy.2007.01.810
Peer Reviewed verified by ORBi

Coton, X., Pinto, E., Reggers, J., Hansenne, M., Parent, M., & Ansseau, M. (2007). Impact de la personnalité sur l'intensité du syndrome de sevrage alcoolique : une étude préliminaire avec le modèle de Cloninger. Encéphale (L'), 33, 264-269. doi:10.1016/s0013-7006(07)92038-2
Peer Reviewed verified by ORBi

Pitchot, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2007). Syndrome de discontinuation associé aux antidépresseurs. Revue Médicale de Liège, 62, 1-4.
Peer reviewed

Scantamburlo, G., Pitchot, W., Pinto, E., Ansseau, M., & Legros, J.-J. (2007). Therapeutic utilisations of vasopressin and oxytocin in mood disorders. Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, 1, 157-161.
Peer reviewed

Pinto, E. (2006). Craving for alcohol : a psychogenetic approach [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/314800

Scantamburlo, G., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2005). AVP- and OT-neurophysins response to apomorphine and clonidine in major depression. Psychoneuroendocrinology, 30 (9), 839-845. doi:10.1016/j.psyneuen.2005.04.015
Peer Reviewed verified by ORBi

Pinto, E., Gorwood, P., Reggers, J., Vaira, D., Fuchs, S., & Pitchot, W. (March 2005). Alcohol craving and the A1 allele of the D2 dopamine receptor gene. European Psychiatry, 20 (Suppl. 1), 25.
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Pinto, E., Reggers, J., Fuchs, S., & Ansseau, M. (2005). 5-Hydroxytryptamine 1A receptors, major depression, and suicidal behavior. Biological Psychiatry, 58 (11), 854-8. doi:10.1016/j.biopsych.2005.05.042
Peer Reviewed verified by ORBi

Scantamburlo, G., Fuchs, S., Pitchot, W., Pinto, E., Reggers, J., Ansseau, M., & Legros, J.-J. (October 2004). Neurohypophyseal response to apomorphine and clonidine stimulation in major depression. European Neuropsychopharmacology, 14 (Suppl. 3), 291-S292. doi:10.1016/S0924-977X(04)80355-9
Peer Reviewed verified by ORBi

Fuchs, S., Reggers, J., Pinto, E., Scantamburlo, G., Pitchot, W., Hansenne, M., Maertens De Noordhout, A., & Ansseau, M. (October 2004). Therapeutic application of right prefrontal low repetitive transcranial magnetic stimulation on depressed patients. European Neuropsychopharmacology, 14 (Suppl. 3), 226. doi:10.1016/S0924-977X(04)80206-2

Pinto, E., & Ansseau, M. (May 2004). Les alcoolisations paroxystiques. Revue Médicale de Liège, 59 (5), 297-300.

Charlier, C., Broly, F., Pinto, E., Ansseau, M., Plomteux, G., & Lhermitte, M. (December 2003). Polymorphisms in the CYP 2D6 gene: Association with plasma concentrations of fluoxetine and paroxetine. Therapeutic Drug Monitoring, 25 (6), 738-742. doi:10.1097/00007691-200312000-00014
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Hansenne, M., Pitchot, W., Fuchs, S., Gorwood, P., Vaira, D., & Ansseau, M. (September 2003). Relationships between DRD2 and DAT polymorphisms and personality traits in healthy subjects. European Neuropsychopharmacology, 13 (Suppl. 4), 427-S428. doi:10.1016/S0924-977X(03)92300-5
Peer Reviewed verified by ORBi

De Witte, P., Pinto, E., Ansseau, M., & Verbanck, P. (May 2003). Alcohol and withdrawal: from animal research to clinical issues. Neuroscience and Biobehavioral Reviews, 27 (3), 189-197. doi:10.1016/S0149-7634(03)00030-7
Peer Reviewed verified by ORBi

Hansenne, M., Pinto, E., Scantamburlo, G., Renard, B., Reggers, J., Fuchs, S., Pitchot, W., & Ansseau, M. (2003). Harm avoidance is related to mismatch negativity (MMN) amplitude in healthy subjects. Personality and Individual Differences, 34 (6), 1039-1048. doi:10.1016/S0191-8869(02)00088-0
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Fuchs, S., Venneman, I., Lamy, M., & Ansseau, M. (2003). Toxicomanes: sevrage ultrarapide aux opiacés sous anesthésie générale au CHU de Liège. Agenda Psychiatrie, 28, 1-2.
Peer reviewed

Pitchot, W., Reggers, J., Pinto, E., Hansenne, M., & Ansseau, M. (2003). Catecholamine and HPA axis dysfunction in depression : relationship with suicidal behavior. Neuropsychobiology, 47 (3), 152-157. doi:10.1159/000070585
Peer Reviewed verified by ORBi

Hansenne, M., Olin, C., Pinto, E., Pitchot, W., & Ansseau, M. (2003). Event-related potentials to emotional and neutral stimuli in alcoholism. Neuropsychobiology, 48 (2), 77-81. doi:10.1159/000072881
Peer Reviewed verified by ORBi

Hansenne, M., Pinto, E., Scantamburlo, G., Couvreur, A., Reggers, J., Fuchs, S., Pitchot, W., & Ansseau, M. (2003). Mismatch negativity is not correlated with neuroendocrine indicators of catecholaminergic activity in healthy subjects. Human Psychopharmacology, 18 (3), 201-5. doi:10.1002/hup.468
Peer Reviewed verified by ORBi

Charlier, C., Pinto, E., Ansseau, M., & Plomteux, G. (December 2002). Venlafaxine: the relationship between dose, plasma concentration and clinical response in depressive patients. Journal of Psychopharmacology, 16 (4), 369-372. doi:10.1177/026988110201600413
Peer Reviewed verified by ORBi

Pitchot, W., Wauthy, J., Hansenne, M., Pinto, E., Fuchs, S., Reggers, J., Legros, J.-J., & Ansseau, M. (October 2002). Hormonal and temperature responses to the 5-HT1a receptor agonist flesinoxan in normal volunteers. Psychopharmacology, 164 (1), 27-32. doi:10.1007/s00213-002-1177-0
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Scantamburlo, G., Fuchs, S., Pirard, S., & Ansseau, M. (2002). 5-HT1A dysfunction in borderline personality disorder. Psychological Medicine, 32 (5), 935-41. doi:10.1017/S0033291702005445
Peer Reviewed verified by ORBi

Hansenne, M., Pinto, E., Pitchot, W., Reggers, J., Scantamburlo, G., Moor, M., & Ansseau, M. (2002). Further evidence on the relationship between dopamine and novelty seeking: a neuroendocrine study. Personality and Individual Differences, 33 (6), 967-977. doi:10.1016/S0191-8869(01)00205-7
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., PITCHOT, W., Hansenne, M., Fuchs, S., & Ansseau, M. (2002). Neuroendocrine evaluation of 5-HT1A function in male alcoholic patients. Psychoneuroendocrinology, 27 (7), 873-879. doi:10.1016/S0306-4530(01)00088-9
Peer Reviewed verified by ORBi

Pitchot, W., Hansenne, M., Gonzalez Moreno, A., Pinto, E., Reggers, J., Fuchs, S., Pirard, S., & Ansseau, M. (October 2001). Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality. Psychoneuroendocrinology, 26 (7), 689-696. doi:10.1016/S0306-4530(01)00021-X
Peer Reviewed verified by ORBi

PITCHOT, W., Reggers, J., Pinto, E., Hansenne, M., Fuchs, S., Pirard, S., & Ansseau, M. (April 2001). Reduced dopaminergic activity in depressed suicides. Psychoneuroendocrinology, 26 (3), 331-335. doi:10.1016/S0306-4530(00)00047-0
Peer Reviewed verified by ORBi

Pinto, E., Reggers, J., Delhez, M., Fuchs, S., Venneman, I., Lamy, M., & Ansseau, M. (2001). Le sevrage ultra-rapide des toxicomanes aux opiaces sous anesthésie générale: resultats préliminaires du protocole liégeois. Revue Médicale de Liège, 56 (8), 572-576.
Peer reviewed

Pinto, E., Reggers, J., Delhez, M., Fuchs, S., VENNEMAN, I., Lamy, M., & ANSSEAU, M. (2001). Le sevrage ultra-rapide des toxicomanes aux opiaciés sous anesthiésie géniérale: Résultats préliminaires du protocole Liègeois. Revue Médicale de Liège, 56 (8), 572-576.
Peer reviewed

Pitchot, W., Hansenne, M., Pinto, E., Reggers, J., Fuchs, S., & Ansseau, M. (2001). Alpha-2-adrenoreceptors in depressed suicide attempters : relationship with medical lethality of the attempt. Neuropsychobiology, 44 (2), 91-94. doi:10.1159/000054923
Peer Reviewed verified by ORBi

Charlier, C., Pinto, E., Ansseau, M., & Plomteux, G. (August 2000). Relationship between Clinical Effects, Serum Drug Concentration, and Concurrent Drug Interactions in Depressed Patients Treated with Citalopram, Fluoxetine, Clomipramine, Paroxetine or Venlafaxine. Human Psychopharmacology, 15 (6), 453-459. doi:10.1002/1099-1077(200008)15:6<453::AID-HUP228>3.0.CO;2-F
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Pinto, E., Reggers, J., Papart, P., & Ansseau, M. (2000). P300 event-related brain potential and personality in depression. European Psychiatry, 15 (6), 370-7. doi:10.1016/S0924-9338(00)00505-8
Peer Reviewed verified by ORBi

Ansseau, M., Besson, J., Lejoyeux, M., Pinto, E., Landry, U., Cornes, M., Deckers, F., Potgieter, A., & Ades, J. (2000). A French translation of the obsessive-compulsive drinking scale for craving in alcohol-dependent patients: A validation study in Belgium, France, and Switzerland. European Addiction Research, 6 (2), 51-6. doi:10.1159/000019010
Peer Reviewed verified by ORBi

Hansenne, M., Pitchot, W., Pinto, E., Papart, P., & Ansseau, M. (2000). Serotonergic-1a activity and contingent negative variation. Biological Psychology, 52 (3), 259-65. doi:10.1016/S0301-0511(99)00047-2
Peer Reviewed verified by ORBi

Papart, P., WEERTS, P., Pinto, E., Hansenne, M., & Ansseau, M. (2000). Relationship between CNV topography and irritability in depression. Journal of Psychophysiology, 14 (Suppl 1).
Peer reviewed

Charlier, C., Ansseau, M., Pinto, E., Andrien, F., & Plomteux, G. (1999). Le controle thérapeutique des médicaments antidépresseurs. Annales de Biologie Clinique, 57 (4, Jul-Aug), 463-8.
Peer Reviewed verified by ORBi

Hansenne, M., Reggers, J., Pinto, E., Kjiri, K., Ajamier, A., & Ansseau, M. (1999). Temperament and character inventory (TCI) and depression. Journal of Psychiatric Research, 33 (1), 31-6. doi:10.1016/S0022-3956(98)00036-3
Peer Reviewed verified by ORBi

Charlier, C., Ansseau, M., Pinto, E., Andrien, F., & Plomteux, G. (1997). Manifestations indésirables des antidépresseurs. Toxicorama, (Spécial LYON), 310-314.
Peer reviewed

Contact ORBi